Development of a Nomogram to Predict N2 or N3 Stage in T1-2 Invasive Breast Cancer Patients with No Palpable Lymphadenopathy.
about
Development of a Nomogram to Predict N2 or N3 Stage in T1-2 Invasive Breast Cancer Patients with No Palpable Lymphadenopathy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Development of a Nomogram to P ...... h No Palpable Lymphadenopathy.
@en
Development of a Nomogram to P ...... h No Palpable Lymphadenopathy.
@nl
type
label
Development of a Nomogram to P ...... h No Palpable Lymphadenopathy.
@en
Development of a Nomogram to P ...... h No Palpable Lymphadenopathy.
@nl
prefLabel
Development of a Nomogram to P ...... h No Palpable Lymphadenopathy.
@en
Development of a Nomogram to P ...... h No Palpable Lymphadenopathy.
@nl
P2093
P2860
P1476
Development of a Nomogram to P ...... h No Palpable Lymphadenopathy.
@en
P2093
Hee Jun Choi
Jai Min Ryu
Jai Myeong Kim
Jeong Eon Lee
Jong Hwan Yu
Se Kyung Lee
Seok Jin Nam
Seok Won Kim
P2860
P304
P356
10.4048/JBC.2017.20.3.270
P577
2017-09-22T00:00:00Z